High quality raw material for IVD manufacturing industry

Recombinant chimeric antigen ChimLyme for Borrelia burgdorferi

RekomBiotech
Borrelia burgdorferi

ChimLyme is a chimeric multiantigen for Lyme Disease produced by Borrelia burgdorferi sensu stricto.

View more information about Borreliosis or Lyme disease.

REFERENCES
COA RAG0027 (B. burgdorferi, chimera) WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow
DESCRIPTION
Recombinant chimeric antigen for Borrelia burgdorferi
PURITY
>95% in a SDS-PAGE
SHIPPING AND STORAGE CONDITIONS
Proteins will be shipped with dry ice or lyophilized. Upon arrival (if liquid), or after reconstitution (if lyophilized), they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles
STABILITY
The protein will remain stable for four years if stored frozen
SPECIFICITY
The protein is immunoreactive against seropositive individuals to Borreliosis or Lyme disease
IVD
Serodiagnosis of Lyme disease
EVALUATION
Recombinant chimeric antigen ChimLyme for Borrelia burgdorferi
RELATED POSTS
Chimeras: multi-epitope antigens
PROMOTIONAL MATERIAL
Catalogue
Lyophilised recombinant antigens
Rekom raw material for Lyme disease IVD
Chimeras: multi-epitope antigens
RELATED PRODUCTS
ospC, p41, VlsE

Also avaliable for detection of Borreliosis or Lyme disease in animals

FOR RESEARCH AND COMERCIAL USE IVD ONLY (*)

(*) Our antigens are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our antigens, you can visit here.

RETURN TO HUMAN RECOMBINANT ANTIGENS